GVT
CRL icon

Genesee Valley Trust’s Charles River Laboratories CRL Stock Holding History

Genesee Valley Trust’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$330K Sell
3,096
-37
-1% -$3.99K 0.13% 137
2017
Q4 		$343K Sell
3,133
-123
-4% -$13.4K 0.14% 138
2017
Q3 		$352K Buy
+3,256
New +$335K 0.14% 131

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Genesee Valley Trust's CRL Position: Q1 2018 in Review

Genesee Valley Trust reduced its Charles River Laboratories (CRL) stake by 1.2% in Q1 2018, selling an estimated $3.99K and leaving 3,096 shares worth $330K. The position accounts for 0.13% of the portfolio, ranked #137.

Genesee Valley Trust first reported a position in CRL in Q3 2017 and has held it in 3 quarters since. The position peaked at $352K in Q3 2017. 333 funds tracked by Wall St. Rank hold CRL as of Q1 2018.

  • Genesee Valley Trust held 3,096 shares of Charles River Laboratories worth $330K as of Q1 2018.
  • Genesee Valley Trust sold 37 Charles River Laboratories shares in Q1 2018, an estimated $3.99K.
  • Charles River Laboratories made up 0.13% of Genesee Valley Trust's portfolio in Q1 2018, its #137 holding.
  • Genesee Valley Trust first reported a position in Charles River Laboratories in Q3 2017 and has held it in 3 quarters since.
  • Genesee Valley Trust's Charles River Laboratories position peaked at $352K in Q3 2017.
  • 333 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2018.

Based on Genesee Valley Trust's 13F filing for Q1 2018, filed 3 Apr 2018.